Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ILOPROST for Cor pulmonale chronic: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 65 adverse event reports in the FDA FAERS database where ILOPROST was used for Cor pulmonale chronic.

Most Reported Side Effects for ILOPROST

Side Effect Reports % Deaths Hosp.
Death 1,369 27.6% 1,369 274
Dyspnoea 662 13.3% 188 485
Headache 353 7.1% 39 173
Cough 284 5.7% 61 176
Pulmonary arterial hypertension 284 5.7% 169 177
Hospitalisation 281 5.7% 47 279
Fatigue 280 5.6% 59 158
Dizziness 225 4.5% 28 133
Pneumonia 224 4.5% 75 200
Pulmonary hypertension 216 4.4% 125 133
Nausea 201 4.1% 32 117
Fluid retention 182 3.7% 54 161
Chest pain 178 3.6% 29 139
Condition aggravated 177 3.6% 75 110
Drug ineffective 176 3.6% 79 63

Other Indications for ILOPROST

Pulmonary arterial hypertension (2,828) Pulmonary hypertension (1,123) Product used for unknown indication (730) Morphoea (14) Systemic scleroderma (14) Foetal exposure during pregnancy (12) Vasodilatation (12) Maternal exposure during pregnancy (11) Pulmonary fibrosis (10) Scleroderma (10)

Other Drugs Used for Cor pulmonale chronic

TREPROSTINIL (1,407) AMBRISENTAN (879) MACITENTAN (254) EPOPROSTENOL (239) BOSENTAN\BOSENTAN (238) REMODULIN (220) TYVASO (143) TRACLEER (101) BOSENTAN (60) VELETRI (43)

Related Pages

ILOPROST Full Profile All Cor pulmonale chronic Drugs ILOPROST Demographics ILOPROST Timeline